Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Scott Davison"'
Autor:
Frank Alvaro, G.J. Dore, David Prince, Miriam T. Levy, Geoff McCaughan, Hong Foo, Melissa A Fraser, Scott Davison, Paul M. Middleton, Michael Maley, Joseph Louis Pipicella
Publikováno v:
Journal of Viral Hepatitis. 28:121-128
The World Health Organization has set ambitious viral hepatitis elimination targets; however, difficulties in identifying and engaging patients remain. The emergency visit is an opportunity for enhanced linkage to care (LTC). We assessed the effectiv
Autor:
Niamh Buckley, Behzad Hajarizadeh, Scott Davison, Miriam T. Levy, Mark Danta, Ian Lockart, Gregory J. Dore, Jacob George, Emilia Prakoso
Publikováno v:
Journal of gastroenterology and hepatologyReferences. 36(12)
BACKGROUND AND AIM Hepatitis C virus (HCV) cure with direct-acting antiviral (DAA) therapy improves survival in patients with HCV-related hepatocellular carcinoma (HCC). We hypothesized that HCV-HCC survival has increased in the DAA era, more than ot
Autor:
Scott Davison, Ann Glass, Waled Mohsen, Miriam T. Levy, Sanjeev Arora, Patrick Chan, Marlize Mouton, Tenzin Lama, Quyen Tran, Cherry Cobrador, Michelle C Whelan, Ernest Young
Publikováno v:
Internal Medicine Journal. 49:351-357
BACKGROUND Although hepatitis C virus (HCV) infection is curable, treatment of difficult to access populations (DTAP) presents unique challenges. Project ECHO (PE) (Extension for Community Healthcare Outcomes) is a telementoring programme adopted to
Autor:
Maryam Alavi, Behzad Hajarizadeh, Miriam T. Levy, Gregory J. Dore, Scott Davison, Ian Lockart, Jacob George, Mark Danta, Emilia Prakoso
Publikováno v:
Journal of viral hepatitisREFERENCES. 28(5)
The impact of hepatitis C virus (HCV) cure on survival in patients with HCV-related hepatocellular carcinoma (HCC) has been examined, although many studies have been subject to survivor treatment selection bias. We assessed the impact of HCV cure bef
Publikováno v:
Alimentary pharmacologytherapeuticsREFERENCES. 51(1)
Publikováno v:
Hepatobiliarypancreatic diseases international : HBPD INT. 19(6)
Despite efficacy in HCV eradication, direct-acting antiviral (DAA) therapy has raised controversies around their impact on hepatocellular carcinoma (HCC) incidence. Herein we reported the first Australian data on HCC incidence in DAA-treated HCV pati
Autor:
A. Glass, Stephen Locarnini, Kathy Jackson, Vi Nguyen, Cynthuja Thilakanathan, Scott Davison, A. Lee, Nicholas A. Shackel, Miriam T. Levy, Joseph Lawler, Gabrielle Wark, Michael Maley
Publikováno v:
Liver International. 38:1212-1219
BACKGROUND & AIMS Antipartum antiviral therapy in the setting of high viral load is recommended to prevent mother-to-child transmission of hepatitis B although recommended viral load cut-offs vary. Quantitative HBsAg has been proposed as an alternati
Autor:
Scott, Davison
Publikováno v:
Journal of law and medicine. 26(3)
Therapeutic privilege is conceptualised as a defence to a negligence claim available to a medical practitioner, where the negligence alleged is a failure to warn. It affords a practitioner an opportunity to prove that the failure to warn was because
Autor:
Vi Nguyen, Kathy Jackson, Dev Samarasinghe, A. Glass, Miriam T. Levy, Susan Holdaway, Astrid-Jane Greenup, Ushmi Chatterjee, Stephen Locarnini, Scott Davison, Pok Kern Tan
Publikováno v:
Journal of Hepatology. 61:502-507
Background & Aims Perinatal transmission of hepatitis B virus still occurs despite immunoprophylaxis in approximately 9% of children from highly viraemic mothers. Antiviral therapy in this setting has been suggested, however with limited evidence to
Publikováno v:
Journal of Hepatology. 64:S360